Sign In
Buy NYXH
$2.87
-0.100 (-3.37%)
At Close: Jun 03, 2026
Information on the total number of voting rights and shares
04:30pm, Wednesday, 20'th May 2026
REGULATED INFORMATION Information on the total number of voting rights and shares Mont-Saint-Guibert (Belgium), May 20, 2026 , 10:30 pm CET / 4:30 pm ET – In accordance with article 15 of the L
Nyxoah Welcomes the Flemish Investors Federation (VFB) at LégiaPark following Q1 2026 Results and U.S. Commercial Momentum
04:05pm, Wednesday, 20'th May 2026
Nyxoah Welcomes the Flemish Investors Federation (VFB) at LégiaPark following Q1 2026 Results and U.S. Commercial Momentum
Nyxoah SA (NYXH) Presents at Bank of America Global Healthcare Conference 2026 Prepared Remarks Transcript
10:20pm, Wednesday, 13'th May 2026
Nyxoah SA (NYXH) Presents at Bank of America Global Healthcare Conference 2026 Prepared Remarks Transcript
Nyxoah SA (NYXH) Q1 2026 Earnings Call Transcript
09:50pm, Tuesday, 12'th May 2026
Nyxoah SA (NYXH) Q1 2026 Earnings Call Transcript
Nyxoah Q1 Earnings Call Highlights
09:09pm, Tuesday, 12'th May 2026
Nyxoah NASDAQ: NYXH reported 13% sequential worldwide net revenue growth in the first quarter of 2026, driven primarily by continued adoption of its Genio system in the United States, where the compan
Nyxoah SA (NYXH) Reports Q1 Loss, Tops Revenue Estimates
08:01pm, Tuesday, 12'th May 2026
Nyxoah SA (NYXH) came out with a quarterly loss of $0.43 per share versus the Zacks Consensus Estimate of a loss of $0.54. This compares to a loss of $0.63 per share a year ago.
Nyxoah Publie ses Résultats Financiers et Opérationnels du Premier Trimestre 2026
04:05pm, Tuesday, 12'th May 2026
INFORMATIONS RÉGLEMENTÉES Nyxoah Publie ses Résultats Financiers et Opérationnels du Premier Trimestre 2026 Le lancement réussi de Genio aux États-Unis génère une croissance trimestrielle séq
Nyxoah Reports First Quarter 2026 Financial and Operating Results
04:05pm, Tuesday, 12'th May 2026
REGULATED INFORMATION Nyxoah Reports First Quarter 2026 Financial and Operating Results Strong Genio launch in the U.S. drove 25% sequential quarterly U.S. revenue growth Continued clarity around HGNS
Nyxoah SA (NYXH) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
11:00am, Tuesday, 05'th May 2026
Nyxoah (NYXH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Nyxoah to Release First Quarter 2026 Financial Results on May 12, 2026
04:05pm, Tuesday, 28'th Apr 2026
Nyxoah to Release First Quarter 2026 Financial Results on May 12, 2026 Mont-Saint-Guibert, Belgium – April 28, 2026, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah
Financial Analysis: Omnicell (NASDAQ:OMCL) versus Nyxoah (NASDAQ:NYXH)
02:14am, Sunday, 22'nd Mar 2026
Nyxoah (NASDAQ: NYXH - Get Free Report) and Omnicell (NASDAQ: OMCL - Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based
Analyzing Rennova Health (OTCMKTS:RNVA) & Nyxoah (NASDAQ:NYXH)
01:12am, Saturday, 21'st Mar 2026
Rennova Health (OTCMKTS:RNVA - Get Free Report) and Nyxoah (NASDAQ: NYXH - Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two companies ba
Publication relating to transparency notifications
05:30pm, Friday, 20'th Mar 2026
REGULATED INFORMATION Publication relating to transparency notifications Mont-Saint-Guibert (Belgium), March 20, 2026 , 10:30 pm CET / 5:30 pm ET – In accordance with article 14 of the Act of 2 May
Nyxoah SA (NYXH) Q4 2025 Earnings Call Transcript
07:32pm, Thursday, 19'th Mar 2026
Nyxoah SA (NYXH) Q4 2025 Earnings Call Transcript
Nyxoah SA (NYXH) Reports Q4 Loss, Misses Revenue Estimates
06:46pm, Thursday, 19'th Mar 2026
Nyxoah SA (NYXH) came out with a quarterly loss of $0.68 per share versus the Zacks Consensus Estimate of a loss of $0.65. This compares to a loss of $0.49 per share a year ago.
